FDA Commissioner Marty Makary Resigns Over Internal Tensions
Summary
FDA Commissioner Marty Makary resigned, with Kyle Diamantas named as acting commissioner, following reports of clashes with lawmakers, pharmaceutical companies, and President Trump, particularly over fruit-flavored vapes.
How coverage differs
Left outlets frame FDA Commissioner Marty Makary's resignation as a result of broad internal tensions and clashes, while right outlets attribute it to his ‘irrational resistance’ to flavored nicotine vapes.
- Left: FDA Commissioner resigns amid internal strife and political clashes Left-leaning outlets report FDA Commissioner Marty Makary's resignation stemmed from significant internal tensions and clashes with President Trump, lawmakers, and pharmaceutical companies. They highlight the specific disagreements over regulating fruit-flavored vapes as a key factor in his departure.
- Right: Anti-vape dogma trumped science, forcing FDA commissioner's departure Right-leaning outlets attribute FDA Commissioner Marty Makary's resignation primarily to his 'irrational resistance' to flavored nicotine vapes. They suggest his stance on these products was a problematic factor leading to his departure from the agency.